Gian Matteo Rigolin
About
In The Last Decade
Gian Matteo Rigolin
112 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 98
- Genetics 1.1k
- Molecular Biology 904
- Hematology 831
- Pathology and Forensic Medicine 764
- Oncology 710
Countries citing papers authored by Gian Matteo Rigolin
This map shows the geographic impact of Gian Matteo Rigolin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian Matteo Rigolin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian Matteo Rigolin more than expected).
Fields of papers citing papers by Gian Matteo Rigolin
This network shows the impact of papers produced by Gian Matteo Rigolin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian Matteo Rigolin. The network helps show where Gian Matteo Rigolin may publish in the future.
Co-authorship network of co-authors of Gian Matteo Rigolin
This figure shows the co-authorship network connecting the top 25 collaborators of Gian Matteo Rigolin. A scholar is included among the top collaborators of Gian Matteo Rigolin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian Matteo Rigolin. Gian Matteo Rigolin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 6 | |
| 5 | 12 | |
| 6 | AN EXTENSIVE MOLECULAR CYTOGENETIC CHARACTERIZATION IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA IDENTIFIES KARYOTYPE ABERRATIONS AND TP53 DISRUPTION AS PREDICTORS OF OUTCOME AND CHEMOREFRACTORINESS | 1 |
| 7 | 6 | |
| 8 | HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB | 0 |
| 9 | 8 | |
| 10 | 20 | |
| 11 | 41 | |
| 12 | Primary Skull Base Lymphoma with Concomitant Petrous Cholesteatoma: Case Report | 0 |
| 13 | 1 | |
| 14 | 20 | |
| 15 | 1 | |
| 16 | Survival of elderly patients with acute myeloid leukemia. | 49 |
| 17 | 83 | |
| 18 | Cytofluorimetric analysis of cytokine receptors in blast cells from acute leukemia. Clinical and biological implications | 1 |
| 19 | 10 | |
| 20 | Study of prognosis in acute myeloid leukemias (AML) by cluster analysis. | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.